|
Delayed
Japan Exchange
10:30:00 30/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 1,363.00 JPY | +0.85% |
|
+1.45% | -7.72% |
Business description: Nipro Corporation
Number of employees: 38,593
Sales by Activity: Nipro Corporation
| Fiscal Period: March | 2022 (JPY) | 2023 (JPY) | 2024 (JPY) | 2025 (JPY) | 2026 (JPY) |
|---|---|---|---|---|---|
Medical Related | 380B | 426B | 459B | 512B | 531B |
Pharmaceutical related | 94.98B | 95.23B | 130B | 143B | 142B |
Pharma Packaging | 52.49B | 57.72B | 64.29B | 66.1B | 62.01B |
Others | 2.66B | 4.44B | 4.96B | 7.29B | 7.1B |
Unallocated Adjustment | -35.18B | -38.26B | -71.4B | -83.78B | -81.2B |
Geographical breakdown of sales: Nipro Corporation
| Fiscal Period: March | 2022 (JPY) | 2023 (JPY) | 2024 (JPY) | 2025 (JPY) | 2026 (JPY) |
|---|---|---|---|---|---|
Japan | 280B | 290B | 305B | 314B | 309B |
Asia | 76.08B | 88.64B | 96.96B | 107B | 101B |
Europe | 60.38B | 68.29B | 77.2B | 92.63B | 50.34B |
U.S.A | 78.24B | 98.09B | 108B | 130B | 42.82B |
Executive Committee: Nipro Corporation
| Manager | Title | Age | Since |
|---|---|---|---|
Takehito Yogo
DFI | Director of Finance/CFO | 58 | 01/06/2025 |
| President | 58 | 01/06/2025 | |
| Chief Administrative Officer | - | - | |
Kimihito Minoura
ADM | Chief Administrative Officer | 54 | 01/04/2005 |
Yasushi Ohyama
PRN | Corporate Officer/Principal | 63 | 01/02/2013 |
Composition of the Board of Directors: Nipro Corporation
| Director | Title | Age | Since |
|---|---|---|---|
Yoshihiko Sano
CHM | Chairman | 81 | 26/06/2025 |
Kimihito Minoura
BRD | Director/Board Member | 54 | 01/06/2009 |
| Director/Board Member | 58 | 01/06/2009 | |
Yasushi Ohyama
BRD | Director/Board Member | 63 | 01/06/2013 |
Takehito Yogo
BRD | Director/Board Member | 58 | 01/06/2015 |
Toshiaki Hattori
BRD | Director/Board Member | 72 | 01/06/2022 |
| Director/Board Member | 70 | 01/06/2024 | |
| Director/Board Member | 74 | 01/06/2024 | |
Mikako Tanaka
BRD | Director/Board Member | 59 | 26/06/2026 |
Holdings: Nipro Corporation
| Name | Stocks | % | Valuation |
|---|---|---|---|
NIPRO CORPORATION 4.53% | 7,764,300 | 4.53% | 68 M $ |
| 1,254,000 | 1.4% | 40 M $ | |
| 3,296,000 | 15% | 8 M $ | |
SHIBUYA CORPORATION 0.53% | 150,000 | 0.53% | 5 M $ |
RENGO CO., LTD. 0.13% | 360,000 | 0.13% | 3 M $ |
| 363,000 | 0.5% | 3 M $ | |
| 400,000 | 1.94% | 3 M $ | |
| 108,970 | 0.04% | 1 M $ | |
GROWTH X PARTNERS,INC. 3.85% | 130,000 | 3.85% | 1 M $ |
| 60,000 | 0.13% | 936 265 $ |
Company details: Nipro Corporation
Group companies: Nipro Corporation
| Name | Category and Sector |
|---|---|
Nipro PharmaPackaging India Pvt Ltd.
 Nipro PharmaPackaging India Pvt Ltd. Medical SpecialtiesHealth Technology Manufactures glass tubing products |
Medical Specialties
|
Nipro Pharmapackaging International NV
 Nipro Pharmapackaging International NV Miscellaneous Commercial ServicesCommercial Services Provides packaging services |
Miscellaneous Commercial Services
|
Nipro Medical Europe NV
 Nipro Medical Europe NV Medical DistributorsDistribution Services Distributes and markets Nipro medical products across Europe, Africa, Russian and the Middle East |
Medical Distributors
|
Nipro Group Cos. NV |
Other Medical Equipment, Supplies & Distribution
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.85% | +1.45% | -9.31% | +21.16% | 1.42B | |
| +1.88% | +2.01% | -15.96% | +12.62% | 181B | |
| +2.55% | +1.52% | -15.65% | +19.03% | 120B | |
| +2.46% | +0.54% | +5.87% | +39.87% | 119B | |
| +0.28% | +0.59% | -44.02% | +6.06% | 91.44B | |
| +1.91% | -2.35% | -0.79% | +76.15% | 63.07B | |
| -0.46% | +0.42% | +8.19% | +82.97% | 55.8B | |
| +1.63% | -1.04% | +9.27% | -21.17% | 54.03B | |
| +2.32% | +1.63% | -8.23% | +47.17% | 45.38B | |
| +1.94% | +1.59% | -1.11% | -6.94% | 34.37B | |
| Average | +1.29% | +0.51% | -7.18% | +27.69% | 76.49B | |
| Weighted average by Cap. | +1.35% | +0.76% | -9.94% | +26.24% |
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 8086 Stock
- Company Nipro Corporation
Select your edition
All financial news and data tailored to specific country editions
